Thomas G. Graeber

33.7k total citations · 10 hit papers
141 papers, 14.7k citations indexed

About

Thomas G. Graeber is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Thomas G. Graeber has authored 141 papers receiving a total of 14.7k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 40 papers in Oncology and 36 papers in Cancer Research. Recurrent topics in Thomas G. Graeber's work include Cancer, Hypoxia, and Metabolism (19 papers), Melanoma and MAPK Pathways (17 papers) and Cancer Genomics and Diagnostics (10 papers). Thomas G. Graeber is often cited by papers focused on Cancer, Hypoxia, and Metabolism (19 papers), Melanoma and MAPK Pathways (17 papers) and Cancer Genomics and Diagnostics (10 papers). Thomas G. Graeber collaborates with scholars based in United States, Germany and United Kingdom. Thomas G. Graeber's co-authors include Amato J. Giaccia, Antoni Ribas, Scott W. Lowe, Tyler Jacks, David E. Housman, Cameron J. Koch, Daniel Braas, Lídia Robert, Jennifer Tsoi and Evangelia Komisopoulou and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Thomas G. Graeber

136 papers receiving 14.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

1996 1.9k citations Thomas G. Graeber, Amato J. Giaccia et al. profile →
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

2017 1.3k citations Ángel García-Díaz, Blanca Homet Moreno et al. profile →
Myc-driven murine prostate cancer shares molecular features with human prostate tumors

2003 593 citations Thomas G. Graeber et al. profile →
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress

2018 583 citations Jennifer Tsoi, Lídia Robert et al. profile →
Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.

1994 515 citations Thomas G. Graeber, Mitchell H. Tsai et al. Molecular and Cellular Biology profile →
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF ^V600E melanoma

2015 435 citations Siwen Hu‐Lieskovan, Stephen Mok et al. Science Translational Medicine profile →
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma

2014 427 citations Jennifer Tsoi, Lídia Robert et al. Nature Communications profile →
Sterol regulatory element–binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity

2013 419 citations Evangelia Komisopoulou, Thomas G. Graeber et al. profile →
Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor

2016 377 citations Thomas G. Graeber et al. Nature Communications profile →
CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis

2023 102 citations Danielle Morrow, Nicholas Bayley et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas G. Graeber United States	52	7.6k	5.3k	3.8k	3.6k	2.3k	141	14.7k
Kongming Wu China	68	8.0k 1.0×	7.6k 1.4×	3.3k 0.9×	4.2k 1.2×	2.5k 1.1×	187	16.5k
Zora Modrušan United States	69	10.6k 1.4×	4.9k 0.9×	3.6k 1.0×	5.0k 1.4×	2.2k 0.9×	166	19.7k
Iman Osman United States	59	7.5k 1.0×	5.9k 1.1×	3.0k 0.8×	2.3k 0.6×	1.8k 0.8×	265	12.5k
Jane B. Trepel United States	74	11.8k 1.5×	4.4k 0.8×	3.2k 0.8×	2.2k 0.6×	2.2k 1.0×	290	17.6k
Kazuaki Takabe United States	60	7.0k 0.9×	4.3k 0.8×	2.8k 0.7×	2.1k 0.6×	2.3k 1.0×	398	12.6k
Fredrik Pontén Sweden	60	8.3k 1.1×	3.7k 0.7×	2.8k 0.7×	1.8k 0.5×	1.8k 0.8×	272	14.2k
Ya Cao China	58	7.2k 0.9×	3.9k 0.7×	4.7k 1.2×	2.2k 0.6×	1.9k 0.8×	311	12.6k
Carsten Müller‐Tidow Germany	64	11.4k 1.5×	4.3k 0.8×	4.3k 1.1×	2.2k 0.6×	1.1k 0.5×	492	18.0k
Øystein Fodstad Norway	68	8.1k 1.1×	5.6k 1.1×	4.5k 1.2×	2.6k 0.7×	2.3k 1.0×	307	14.8k
Dihua Yu United States	73	10.9k 1.4×	9.0k 1.7×	3.9k 1.0×	2.3k 0.7×	2.9k 1.3×	242	19.0k

Countries citing papers authored by Thomas G. Graeber

Since Specialization

Citations

This map shows the geographic impact of Thomas G. Graeber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas G. Graeber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas G. Graeber more than expected).

Fields of papers citing papers by Thomas G. Graeber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas G. Graeber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas G. Graeber. The network helps show where Thomas G. Graeber may publish in the future.

Co-authorship network of co-authors of Thomas G. Graeber

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas G. Graeber. A scholar is included among the top collaborators of Thomas G. Graeber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas G. Graeber. Thomas G. Graeber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fernández, Elízabeth, X. Wilson, Nicholas Bayley, et al.. (2024). Integrated molecular and functional characterization of the intrinsic apoptotic machinery identifies therapeutic vulnerabilities in glioma. Nature Communications. 15(1). 10089–10089. 4 indexed citations

Palermo, Amelia, Shen Li, Johanna ten Hoeve, et al.. (2023). A ketogenic diet can mitigate SARS-CoV-2 induced systemic reprogramming and inflammation. Communications Biology. 6(1). 1115–1115. 6 indexed citations

Morrow, Danielle, Nicholas Bayley, Elízabeth Fernández, et al.. (2023). TMET-12. CDKN2A DELETION REMODELS LIPID METABOLISM TO PRIME GLIOBLASTOMA FOR FERROPTOSIS. Neuro-Oncology. 25(Supplement_5). v275–v275. 1 indexed citations

Hu, Junhui, Ping Tan, Nicholas Bayley, et al.. (2023). Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma. Signal Transduction and Targeted Therapy. 8(1). 155–155. 40 indexed citations

Crane, Jacquelyn, Christine E. Mona, Scott D. Nelson, et al.. (2023). Fibroblast Activation Protein Expression in Sarcomas. Sarcoma. 2023. 1–11. 16 indexed citations

Shia, David W., Preethi Vijayaraj, Cody J. Aros, et al.. (2022). Targeting PEA3 transcription factors to mitigate small cell lung cancer progression. Oncogene. 42(6). 434–448. 12 indexed citations

Bennett, Neal K., Hiroki J. Nakaoka, Johanna ten Hoeve, et al.. (2020). Defining the ATPome reveals cross-optimization of metabolic pathways. Nature Communications. 11(1). 4319–4319. 22 indexed citations

Park, Jung Wook, John K. Lee, Katherine M. Sheu, et al.. (2018). Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage. Science. 362(6410). 91–95. 203 indexed citations

Moreno, Blanca Homet, Jesse M. Zaretsky, Ángel García-Díaz, et al.. (2016). Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells. Cancer Immunology Research. 4(10). 845–857. 104 indexed citations

10.

Hu‐Lieskovan, Siwen, Stephen Mok, Blanca Homet Moreno, et al.. (2015). Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF ^V600E melanoma. Science Translational Medicine. 7(279). 279ra41–279ra41. 435 indexed citations breakdown →

11.

Tong, Maomeng, Ian McHardy, Paul Ruegger, et al.. (2014). Reprograming of gut microbiome energy metabolism by the FUT2 Crohn’s disease risk polymorphism. The ISME Journal. 8(11). 2193–2206. 159 indexed citations

12.

Atefi, Mohammad, Earl Avramis, Amanda Lassen, et al.. (2014). Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma. Clinical Cancer Research. 20(13). 3446–3457. 285 indexed citations

13.

Robert, Lídia, Jennifer Tsoi, Xiaoyan Wang, et al.. (2014). CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire. Clinical Cancer Research. 20(9). 2424–2432. 280 indexed citations

14.

Wong, Deborah J., Lídia Robert, Mohammad Atefi, et al.. (2014). Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma. Molecular Cancer. 13(1). 194–194. 85 indexed citations

15.

Mok, Stephen, Richard C. Koya, Christopher Tsui, et al.. (2013). Inhibition of CSF-1 Receptor Improves the Antitumor Efficacy of Adoptive Cell Transfer Immunotherapy. Cancer Research. 74(1). 153–161. 252 indexed citations

16.

Teles, Rosane M. B., Thomas G. Graeber, Stephan R. Krutzik, et al.. (2013). Type I Interferon Suppresses Type II Interferon–Triggered Human Anti-Mycobacterial Responses. Science. 339(6126). 1448–1453. 296 indexed citations

17.

Drake, Justin M., Nicholas Graham, John K. Lee, et al.. (2013). Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets. Proceedings of the National Academy of Sciences. 110(49). E4762–9. 90 indexed citations

18.

Koya, Richard C., Stephen Mok, Nicholas Otte, et al.. (2012). BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy. Cancer Research. 72(16). 3928–3937. 187 indexed citations

19.

Fang, Cong, Yanju Wang, Nam T. Vu, et al.. (2010). Integrated Microfluidic and Imaging Platform for a Kinase Activity Radioassay to Analyze Minute Patient Cancer Samples. Cancer Research. 70(21). 8299–8308. 51 indexed citations

20.

Graeber, Thomas G., et al.. (1994). Hypoxia Induces Accumulation of p53 Protein, but Activation of a G ₁ -Phase Checkpoint by Low-Oxygen Conditions Is Independent of p53 Status. Molecular and Cellular Biology. 14(9). 6264–6277. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact